Table:
begin	end	state
1	11	cytoplasmic
12	30	transmembrane
31	67	non-cytoplasmic
68	91	transmembrane
92	99	cytoplasmic
100	121	transmembrane
122	126	non-cytoplasmic
127	127	cytoplasmic
128	145	transmembrane
146	159	cytoplasmic
160	181	transmembrane
182	186	non-cytoplasmic
187	207	transmembrane
208	247	cytoplasmic
248	267	transmembrane
268	287	non-cytoplasmic
288	311	transmembrane
312	325	cytoplasmic
326	342	transmembrane
343	347	non-cytoplasmic
348	369	transmembrane
370	380	cytoplasmic
381	406	transmembrane
407	411	non-cytoplasmic
412	434	transmembrane
435	441	cytoplasmic

Input:
>Echvi_3106
MVKIKLNSIIKGYRWRIVALLFLATAIKYIDRNVLSFTMIDEGFRREMLGVSDTTALSSE
LIGKFKILMGYVDASFKFAYAIGFVLMGYFIDRVLVRKGYSIAIAIWSLAGIVTAFVSSF
RGLSFTRFVFGFGESANFPAAIKTIAEWFPKKERSFATGIYNAGANVGIMATVLIVPALI
LNLGWRWSFLCTGLLGLVLLACWLLIYKPPKAHPKVSQDEQEHIHADEESEHEAEKVPWK
DLLKTKGAWAIALGKFLTDPIWWFYLTWLPDFFNSNEALETKLDLTGLALPFIFIYFTSD
LGSVFFGWLSGKFINMGWSLNKSRKVTLLLCALLVVPLIFAAKVANVYVAMVLVALAAAA
HQGWSANLFTLSSDIFPKRVVGSVVGLAGMVGGIGGTIFAAFAGIILVKWGYFPIFIIAS
SAYLLAWLIIHLLVPKIGVRS

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server